Trupanion (NASDAQ:TRUP – Get Free Report) posted its quarterly earnings results on Thursday. The financial services provider reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.05, FiscalAI reports. The firm had revenue of $405.59 million during the quarter, compared to the consensus estimate of $402.53 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. During the same period in the previous year, the firm posted $0.13 earnings per share.
Here are the key takeaways from Trupanion’s conference call:
- Trupanion reported record third-quarter adjusted operating income of $47 million, up 15% year over year, on revenue of $405.6 million, up 11%. Free cash flow also reached a record $28.5 million, and the company reported its sixth consecutive quarter of positive net income.
- Growth and customer metrics improved: net new pets exceeded 20,500, up more than 28% year over year, while average monthly retention rose for the seventh consecutive quarter to 98.38%. Management attributed stronger conversion and lower acquisition cost per pet in part to expanded plan options and digital enrollment improvements.
- The company raised the midpoint of its full-year adjusted operating income outlook to $180.5 million, implying about 19% year-over-year growth, and expects fourth-quarter adjusted operating income of $48 million to $51 million. Full-year subscription revenue is now expected to grow about 14% at the midpoint.
- Management expects veterinary cost inflation to remain in the double digits into 2027, requiring continued pricing adjustments. It said average member increases may ease as pricing catches up with costs, but affordability remains an important consideration.
- Trupanion repurchased about $25 million of shares in the quarter and repaid $15 million of borrowings after quarter-end, while continuing to fund growth initiatives. Its Landspath pet-food trials are underway, but management expects limited revenue from the initiative over the next 18 months.
Trupanion Stock Up 5.8%
Shares of NASDAQ TRUP traded up $2.03 during mid-day trading on Friday, reaching $36.75. 979,101 shares of the company’s stock traded hands, compared to its average volume of 364,995. The stock has a market cap of $1.61 billion, a P/E ratio of 60.25, a PEG ratio of 1.84 and a beta of 1.27. The business has a 50-day simple moving average of $27.14 and a 200 day simple moving average of $26.69. Trupanion has a 1-year low of $21.16 and a 1-year high of $46.98. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77.
Trending Headlines about Trupanion
Here are the key news stories impacting Trupanion this week:
- Positive Sentiment: For Q3 2026, Trupanion reported revenue of $405.6 million, above analysts’ $402.5 million estimate, and EPS of $0.21 versus the $0.16 consensus. EPS also increased from $0.13 a year earlier. Zacks Q3 earnings report
- Positive Sentiment: Q3 call coverage highlighted record adjusted operating income and cash flow, pointing to operating and cash-generation strengths. Q3 earnings call highlights
- Neutral Sentiment: Trupanion forecast Q4 revenue of $407 million–$414 million, a range that brackets the $411.9 million consensus. Its FY 2026 revenue guidance of $1.6 billion matched analysts’ estimate, offering little change to the full-year outlook.
- Negative Sentiment: One earnings recap characterized the quarter as a sharp EPS miss, a caution that may reflect a different earnings measure than the reported $0.21-per-share figure that beat consensus. Q3 earnings recap
Insider Buying and Selling
In related news, COO John Gallagher sold 3,604 shares of the company’s stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the sale, the chief operating officer owned 33,742 shares in the company, valued at $1,002,137.40. This represents a 9.65% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Margaret Tooth sold 1,000 shares of the firm’s stock in a transaction dated Friday, October 9th. The shares were sold at an average price of $25.84, for a total transaction of $25,840.00. Following the completion of the transaction, the chief executive officer directly owned 184,952 shares in the company, valued at approximately $4,779,159.68. The trade was a 0.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 14,046 shares of company stock worth $407,743 in the last quarter. Insiders own 5.58% of the company’s stock.
Analyst Ratings Changes
TRUP has been the subject of several research reports. Atlantic Securities set a $42.00 target price on Trupanion in a research note on Wednesday, July 15th. Zacks Research downgraded Trupanion from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 24th. Stifel Nicolaus increased their price target on Trupanion from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Thursday, August 20th. Wall Street Zen raised Trupanion from a “hold” rating to a “buy” rating in a research note on Saturday. Finally, Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $45.00 to $32.00 in a report on Wednesday, August 26th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $38.40.
Get Our Latest Analysis on TRUP
About Trupanion
Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.
The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.
Read More
- Five stocks we like better than Trupanion
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
